Company

Eagle Pharmaceuticals, Inc.

Headquarters: Woodcliff Lake, NJ, United States

Employees: 102

CEO: Mr. Scott L. Tarriff

NASDAQ: EGRX +4.59%

Market Cap

$66.6 Million

USD as of Jan. 1, 2024

Market Cap History

Eagle Pharmaceuticals, Inc. market capitalization over time

Evolution of Eagle Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Eagle Pharmaceuticals, Inc.

Detailed Description

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Eagle Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: EGRX wb_incandescent

Stock: FSX: 1000000 wb_incandescent

Details

Headquarters:

50 Tice Boulevard

Suite 315

Woodcliff Lake, NJ 07677

United States

Phone: 201 326 5300